CBD

Study researchers from Israel recently discovered that cannabis terpenes can activate endocannabinoid receptors.

The Senate’s reopening the government bill has passed but it includes a section that redefines hemp and can ban hemp products with a greater amount of 0.4 mg total THC.

A study looked into the beneficial role THC-CBD cannabis extracts may play with Alzheimer’s disease-associated dementia.

Our top cannabis news topics this week: new training programs, lawsuits, state enforcement, and clinical research findings.

Recently, the Virginia Cannabis Control Authority established a training program for practitioners through a partnership with TheAnswerPage.com.

In this month’s webinar, Dr. Sulak discusses new studies on various effects and risks of cannabis on driving performance.

Dr. Dustin Sulak reviews studies on medical cannabis in this month’s webinar, including research on Tourette syndrome, chemotherapy-induced neuropathy, and caregiver wellbeing.

Our sister publication, Nutritional Outlook, covered the science, safety, regulatory challenges, and therapeutic potential of nonpsychoactive cannabinoids including CBN, CBG, and CBDA.

According to a recent study, plant-derived cannabis extracts containing THC, CBD, and CBG, may offer superior short-term and long-term pain relief than opioids for chronic lower back pain patients.

Trump highlights hemp-derived CBD for senior healthcare, sparking discussion on cannabis reform, Medicare coverage, and the endocannabinoid system.

What role does cannabis play in skin conditions?

Research highlights benefits of hemp-derived CBD reported by patients with anxiety: reduced anxiety, better sleep, and improved mood.

A new literature review highlights CBD’s potential in skin health, from acne to psoriasis, while exploring delivery challenges and future applications.

The FDA-funded study found that CBD was linked to elevated liver enzymes in some healthy adults, underscoring need for further safety research.

In the second part of this webinar coverage, Dustin Sulak, DO, explains recent research and studies on cannabinoids and their effect on sleep and conditions affecting sleep.

Here, we bring you our top five recent articles covering National CBD Day 2025, medical cannabis patients’ workers’ compensation, Trump looking into cannabis rescheduling, research studies on cannabis for sleep, and a clinical trial for CBD and insomnia.

In this month’s webinar, Dustin Sulak, DO, explains recent research and studies on cannabinoids and their effect on sleep and conditions affecting sleep.

Avecho Biotechnology Limited is looking to recruit more than 500 patients for a clinical trial evaluating the use of a pharmaceutical CBD product to treat insomnia.

In honor of National CBD Day on August 8, 2025, we are excited to share with you our CBD-themed round up of CBD research.

In honor of National CBD Day on August 8, 2025, we are excited to share with you our CBD-themed round up of CBD-related medical research.

Check out our exciting 2025 National CBD Day coverage!

Analysis of two coffee products revealed 70–80% less CBD in the brewed coffee than what was indicated on the label.

Data from a recent study discovered that THC labeling was more accurate in concentrate products than with cannabis flower.

Here, we bring you our top five recent articles covering medical cannabis in Texas, cease-and-desist letter response, pardons in Maryland, cannabis in Thailand, and research on autism and cannabis.

Results included improvements in aggression, hyperactivity, and communication, but a strong placebo effect was also observed.